Akebia Therapeutics
AKBA
#7760
Rank
C$0.49 B
Marketcap
C$1.85
Share price
-4.64%
Change (1 day)
-31.25%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: C$0.49 Billion

As of January 2026 Akebia Therapeutics has a market cap of C$0.49 Billion. This makes Akebia Therapeutics the world's 7760th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.49 B-18.48%
2025C$0.60 B-1.19%
2024C$0.61 B97.04%
2023C$0.30 B115.11%
2022C$0.14 B-71.42%
2021C$0.50 B-2.35%
2020C$0.51 B-48.62%
2019C$1.00 B14.06%
2018C$0.88 B-0.36%
2017C$0.88 B64.83%
2016C$0.53 B-2.44%
2015C$0.54 B99.71%
2014C$0.27 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Akebia Therapeutics was reported to be:

C$0.51 Billion
by Nasdaq info icon info icon
C$0.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
C$242.57 B 49,224.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$377.62 B 76,686.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
C$712.89 B 144,860.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C$1.01 B 106.59%๐Ÿ‡บ๐Ÿ‡ธ USA